has received approval from the
Food and Drug Administration
for two oral contraceptives.
Barr will manufacture and market generic versions of
Ortho-Novum 1/35 tablets and Modicon-28 tablets. Barr, which is based in Pomona, N.Y., will market both drugs as branded generics with the
trademark. The drugs will be available in the fourth quarter of fiscal 2001.
The two drugs have current annual sales of about $80 million, according to Barr.
In recent trading on the
New York Stock Exchange
, Barr gained $2.34, or 4.6%, to $52.85.